– | Poor control of symptoms |
– | Worsening of the quality of life |
– | Increasing number of relapses and more frequent need for health-care services (which account for 35-45% of the disease-related costs) |
– | Higher mortality rate (2–3 times higher than in patients showing good compliance – 26.4% vs. 11.3% according to a sub-analysis made in the TORCH study [28] |
– | Increase in health-care expenditure. |